enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Glipizide - Wikipedia

    en.wikipedia.org/wiki/Glipizide

    Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes. [1] [2] It is used together with a diabetic diet and exercise. [1] [2] It is not indicated for use by itself in type 1 diabetes. [1] [2] It is taken by mouth.

  3. GLP-1 receptor agonist - Wikipedia

    en.wikipedia.org/wiki/GLP-1_receptor_agonist

    A meta-analysis including 13 cardiovascular outcome trials found that SGLT-2 inhibitors reduce the risk for three-point MACE, especially in subjects with an estimated glomerular filtration rate (eGFR) below 60 mL/min, whereas GLP-1 receptor agonists were more beneficial in people with higher eGFR. [12]

  4. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Medical uses [ edit ] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include SGLT2 inhibitors as a first line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease , cardiovascular disease or heart failure .

  5. US FDA approves Novo Nordisk's Ozempic to cut risk of ... - AOL

    www.aol.com/news/us-fda-approves-novo-nordisks...

    Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ingredient as its popular obesity treatment Wegovy. The U.S. Food and ...

  6. Serious Ozempic Side Effects, Confirmed: Here’s What to Know

    www.aol.com/lifestyle/serious-ozempic-side...

    Here’s what the study suggests, plus what a weight loss physician wants you to know. ... Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50. Show comments. Advertisement.

  7. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    In March 2021, in a phase III randomized, double-blind trial, 1,961 adults with a body mass index of 30 or greater were assigned in a 2:1 ratio to a treatment with once-weekly subcutaneous semaglutide or placebo, plus lifestyle intervention. The trials occurred at 129 sites in 16 countries in Asia, Europe, North America, and South America.

  8. Review links 3 potentially-blinding eye conditions to GLP-1 ...

    www.aol.com/review-links-3-potentially-blinding...

    A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye ...

  9. Stylists Say These Are the Best Hairstyles for Women Over 60

    www.aol.com/youthful-celebrity-hairstyles...

    Check out these flattering celebrity hairstyles for women over 60 to look and feel your best. ... use a mask weekly, and don’t turn the iron too high. Plus, get regular trims every eight weeks ...